Reduced baroreflex sensitivity is tied to an increased risk for dementia in older adults who do not take antihypertensive medications.

CVRx, Inc. announced new real-world evidence demonstrating that use of the company’s Barostim implant was associated wit ...

This new study showing significant reductions in real-world healthcare utilization associated with the Barostim implant is critically important for clinicians and payers when considering this device ...